Risk‐reducing mastectomy and salpingo‐oophorectomy in unaffected BRCA mutation carriers: uptake and timing *

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Genetics

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1399-0004.2009.01329.xPMID 20059483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

  2008cited by this paper
• Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers

  2008cited by this paper
• International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

  2008influential reference
• The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

  2008cited by this paper
• Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: a systematic review.

  2008cited by this paper
• Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

  2008cited by this paper
• Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.

  2007cited by this paper
• Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffective

  2007cited by this paper
• Cancer risks among BRCA1 and BRCA2 mutation carriers

  2007cited by this paper
• Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

  2007cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007cited by this paper
• Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status

  2007cited by this paper
• Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic

  2007cited by this paper
• Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families

  2006cited by this paper
• Risk‐reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study

  2006cited by this paper
• Association between clinical characteristics and risk‐reduction interventions in women who underwent BRCA1 and BRCA2 testing

  2006cited by this paper
• Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

  2006cited by this paper
• MRI in the Early Detection of Breast Cancer in Women with High Genetic Risk

  2006cited by this paper
• Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers

  2006cited by this paper
• Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

  2006cited by this paper
• Risk-Reduction Surgery Decisions in High-Risk Women Seen for Genetic Counseling

  2005cited by this paper
• Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status

  2005cited by this paper
• Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

  2005cited by this paper
• Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations

  2004cited by this paper
• Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

  2004cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

  2002cited by this paper
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

  2001cited by this paper
• Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.

  2000cited by this paper
• Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCAmutations

  2000cited by this paper
• Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

  2000cited by this paper
• An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling

  2000cited by this paper
• Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

  1999cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper

• Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers

  2026influential citation
• Preferences of BRCA mutation carriers for attributes of risk‐reducing surgical options for breast and ovarian cancer

  2025cites this paper
• Time trends, uptake, and oncological effects of risk-reducing surgeries in 3067 Danish BRCA1/2 carriers: a population-based study with matched controls

  2025cites this paper
• Bilateral Risk‐Reducing Mastectomy With Immediate Breast Reconstruction Lowers Concerns of Breast Cancer in Women With a High‐Risk Genetic Predisposition for Breast Cancer Compared With a Radiological Imaging Surveillance Group

  2025cites this paper
• Timely access to risk-reducing bilateral mastectomy: a systematic review of uptake, predictors, surgical waiting times and barriers

  2025influential citation
• Risk reducing mastectomy in Norwegian BRCA1/2 carriers.

  2024cites this paper
• Systemic and Local Strategies for Primary Prevention of Breast Cancer

  2024cites this paper
• Uptake of Risk‐Reducing Salpingo‐Oophorectomy and Gynaecologic Surveillance Among Germline BRCA Pathogenic Variants Carriers

  2024influential citation
• A cost-benefit analysis of genetic screening test for breast cancer in Iran

  2024cites this paper
• Counselling Framework for Germline BRCA1/2 and PALB2 Carriers Considering Risk-Reducing Mastectomy

  2024cites this paper
• Psychological distress and decision‐making factors for prophylactic bilateral mastectomy in cancer‐unaffected BRCA1/2 pathogenic variant carriers

  2023cites this paper
• Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis

  2023cites this paper
• Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic

  2023cites this paper
• Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes

  2023cites this paper
• Risk‐reducing mastectomy decisions among women with mutations in high‐ and moderate‐ penetrance breast cancer susceptibility genes

  2022cites this paper
• Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system.

  2022cites this paper
• Management of patients with BRCA mutation from the point of view of a breast surgeon

  2021cites this paper
• Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers

  2021cites this paper
• Prophylactic Surgery in the BRCA+ Patient: Do Women Develop Breast Cancer While Waiting?

  2021cites this paper
• Sexual Function in Women Undergoing Risk Reducing Salpingo-Oophorectomy With or Without Hysterectomy

  2021cites this paper
• The acceptability of prophylactic mastectomy among lay people and health professionals: A pilot study

  2021cites this paper
• Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li–Fraumeni syndrome

  2021cites this paper
• Risk Reducing Mastectomies among Women with Mutations in Moderate Penetrance Breast Cancer Susceptibility Genes

  2021cites this paper
• Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer

  2021cites this paper
• Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea

  2021cites this paper
• Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes

  2021cites this paper
• Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.

  2021cites this paper
• The Biopolitics of Intellectual Property

  2020cites this paper
• Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention

  2020cites this paper
• Surgical Options for Primary Prevention: Prophylactic Mastectomy and Oophorectomy

  2020cites this paper
• Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review

  2020cites this paper
• Genetic testing for breast cancer risk, from BRCA1/2 to a seven gene panel: an ethical analysis

  2020cites this paper
• Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers

  2020cites this paper
• Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study

  2020cites this paper
• Patient perspectives on variant reclassification after cancer susceptibility testing

  2020cites this paper
• Population-based genetic testing for Women's cancer prevention.

  2020influential citation
• Quality of Life after Bilateral and Contralateral Prophylactic Mastectomy with Implant Reconstruction

  2020cites this paper
• Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers.

  2020cites this paper
• Clinical Effects of Early or Surgical Menopause.

  2020cites this paper
• Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer

  2020cites this paper
• Risk-reducing surgery: Uptake & menopausal consequences

  2019cites this paper
• Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome

  2019influential citation
• Bilateral Risk-Reducing Mastectomies with Implant-Based Reconstructions Followed Long Term: A Consecutive Series of 185 Patients

  2019cites this paper
• Exploring factors that impact uptake of risk-reducing bilateral salpingo-oophorectomy (RRBSO) in high-risk women.

  2019cites this paper
• Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

  2019cites this paper
• Spectrum of BRCA1/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study

  2019cites this paper
• Index

  2019cites this paper
• Works Cited

  2019cites this paper
• Patents

  2019cites this paper
• Conclusion: Politics Was Already in the Way

  2019cites this paper
• Preface

  2019cites this paper
• Introduction

  2019cites this paper
• Theorizing Intellectual Property

  2019cites this paper
• Copyright

  2019cites this paper
• Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter

  2018cites this paper
• Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review

  2018cites this paper
• Risk-Reducing Breast and Ovarian Surgery for Women at High Familial Risk

  2018cites this paper
• Uptake of risk‐reducing surgery in BRCA gene carriers in Wales, UK

  2018cites this paper
• Exploration of the decision-making processes, perceptions of risk and psycho-social experiences among young women undergoing bilateral prophylactic mastectomy

  2018influential citation
• Influences on Satisfaction with Reconstructed Breasts and Intimacy in Younger Women Following Bilateral Prophylactic Mastectomy: a Qualitative Analysis

  2018cites this paper
• Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE)

  2018cites this paper
• Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review

  2018cites this paper
• Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women

  2018cites this paper
• Layers of information: interacting constraints on breast cancer risk-management by high-risk African American women

  2018cites this paper
• Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews

  2018cites this paper
• Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer

  2018cites this paper
• Nipple-sparing mastectomy in women at high risk of developing breast cancer.

  2018cites this paper
• Trademark

  2018cites this paper
• Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations

  2017cites this paper
• Screening for familial cancer risk: Focus on breast cancer.

  2017cites this paper
• Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance

  2017cites this paper
• Influences on decision-making for young women undergoing bilateral prophylactic mastectomy.

  2017cites this paper
• Heightened perception of breast cancer risk in young women at risk of familial breast cancer

  2017cites this paper
• Successful Repatriation of Breast Cancer Surveillance for High‐Risk Women to the UK National Health Service Breast Screening Programme

  2017cites this paper
• Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.

  2017cites this paper
• Women's experience of decision-making regarding prophylactic mastectomy

  2017influential citation
• Decision making for breast cancer prevention among women at elevated risk

  2017influential citation
• A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.

  2016cites this paper
• Prophylactic Risk-Reducing Surgery for Breast Cancer

  2016cites this paper
• Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy - A review of the literature.

  2016cites this paper
• Surgical Decision Making in the BRCA‐Positive Population: Institutional Experience and Comparison with Recent Literature

  2016cites this paper
• Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.

  2016cites this paper
• Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.

  2016cites this paper
• Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees.

  2016cites this paper
• Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens.

  2015cites this paper
• Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.

  2015cites this paper
• Psychiatric implications of cancer genetic testing

  2015cites this paper
• RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.

  2015cites this paper
• Intentions for risk‐reducing surgery among high‐risk women referred for BRCA1/BRCA2 genetic counseling

  2015cites this paper
• Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations

  2015cites this paper
• Public perception of risk-reducing salpingectomy for preventing ovarian cancer

  2015cites this paper
• The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy

  2015influential citation
• Predictors that Influence Contralateral Prophylactic Mastectomy Election Among Women with Ductal Carcinoma In Situ Who Were Evaluated for BRCA Genetic Testing

  2014cites this paper
• Timing of prophylactic hysterectomy‐oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers

  2014cites this paper
• BRCA1/2 mutation carriers are potentially at higher cardiovascular risk.

  2014cites this paper
• Breast Cancer Risk-reducing Strategies in BRCA1/2 Mutation Carriers

  2014cites this paper
• Sources of adverse selection in insurance markets with genetic information

  2014cites this paper
• Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing

  2014cites this paper
• Adapting the coping in deliberation (CODE) framework: a multi-method approach in the context of familial ovarian cancer risk management.

  2014influential citation
• Rates of risk‐reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers

  2014cites this paper